SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001085146-24-000649
Filing Date
2024-02-02
Accepted
2024-02-02 12:35:15
Documents
1

Document Format Files

Seq Description Document Type Size
1 COWEN FINANCIAL PRODUCTS LLC scpha1_20224.htm SC 13G/A 25700
  Complete submission text file 0001085146-24-000649.txt   27246
Mailing Address 25 BURLINGTON MALL ROAD, SUITE 203 BURLINGTON MA 01803
Business Address 25 BURLINGTON MALL ROAD, SUITE 203 BURLINGTON MA 01803 617-517-0730
scPharmaceuticals Inc. (Subject) CIK: 0001604950 (see all company filings)

IRS No.: 465184075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-90193 | Film No.: 24589701
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 599 LEXINGTON AVENUE NEW YORK NY 10022
Business Address 599 LEXINGTON AVENUE NEW YORK NY 10022 6465621000
Cowen Financial Products LLC (Filed by) CIK: 0001771015 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A